Antibody-Drug Conjugates: 40 Years of Cancer Treatment Innovation AACR 4 Mins Read Published on May 3, 2025 Antibody-drug conjugates (ADCs) have revolutionized oncology, offering targeted cancer treatments that minimize harm to healthy…
ASCENT Trial: Trodelvy Boosts Survival in Triple-Negative Breast Cancer Breast Cancer 4 Mins Read Overview of the ASCENT Trial and Trodelvy The ASCENT Trial (NCT02574455) is a Phase III study that compares Trodelvy (Sacituzumab…
